Upgrade to SI Premium - Free Trial

Merck (MRK) Ends '12 on High Note Despite SINGULAIR Weakness; '13 EPS Guidance Muted

February 1, 2013 8:48 AM
Shares of Merck (NYSE: MRK) ticked lower early on Friday after the drug maker reported Q4 results. While the EPS ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Hot Earnings

Next Articles